Novonesis A/s Class B · OMXCOP:NSIS_B
Novonesis A/s Class B — FY2020 Earnings Presentation
14 slides from Novonesis A/s Class B's earnings presentation, Feb 2, 2021
Slide 1: Conference call 12M 2020
Conference call 12M 2020 February 2, 2021 X Rethink Tomorrow Z : ' Rn. © - ~~ hovozymes’
Slide 2: Disclaimer
Disclaimer Forward Looking Statement This presentation and its related comments contain forward-looking statements, including statements about future events, future financial performance, plans, strategies and expectations. Forward-looking statements are associated with words such as, but not limite
Slide 3: Highlights
Highlights Resilient 2020 performance despite the COVID-19 pandemic. 2021 expected stronger with outlook of 2-6% organic sales growth and solid EBIT margin and FCF generation * Organic sales; 12M y/y: 0% (Q4 y/y: 3%). * Organic sales performance was mixed across business areas; Household Care solid
Slide 4: Household Care
Latest results Household Care Solid growth in 2020; Q4 impacted by destocking, as expected * Organic sales; 12M y/y: 5% (Q4 y/y: 0%) * Solid sales performance driven by rollout of the freshness technology, increased penetration in emerging markets and supported by increased consumer demand for deter
Slide 5: Food, Beverages & Human Health
Latest results Food, Beverages & Human Health Mixed performance across industries; Q4 declined as expected following destocking in baking * Organic sales; 12M y/y: 1% (Q4 y/y: -4%). * Mixed performance with Food doing well; Beverages al negatively impacted by COVID-19 lockdowns; Human Oy Health prog
Slide 6: Bioenergy
Latest results Bioenergy Continued improvement in Q4, but 2020 significantly below 2019 due to COVID-19-related lockdowns Organic sales; 12M y/y: -9% (Q4 y/y: -4%). U.S. ethanol production significantly impacted by COVID-19 restrictions. Growth across major regions outside of the U.S. Q4 declined as
Slide 7: Grain & Tech Processing
Latest results Grain & Tech Processing Mixed performance in 2020 with significant headwinds in Tech offset by solid growth in Grain; Q4 as expected Organic sales; 12M y/y: -1% (Q4 y/y: -4%). Mixed performance with Tech in decline; solid broad- based growth in Grain. COVID-19 caused a significant dec
Slide 8: Agriculture, Animal Health & Nutrition
Latest results Agriculture, Animal Health & Nutrition Growth driven by Agriculture, while Animal Health & Nutrition declined; Q4 decline driven by timing in BioAg * Organic sales; 12M y/y: 1% (Q4 y/y: -6%). * Agriculture grew, driven by growth across main categories; Q4 declined impacted by timing.
Slide 9: Sustainability and non-financial targets
Sustainability and non-financial targets 2020 ©2022 targets Status Save CO, emissions by enabling low carbon fuels inthe 49 60 million tons Ontrack transport sector of CO, z Reach people by providing laundry solutions that replace 3.98 >4 billion people On track 5 3 chemicals Gain food by improving
Slide 10: Financials - Performance 12M
Financials —- Performance 12M Solid financial performance despite challenging conditions * Organic sales; 12M y/y: 0%; DKK sales -3%. * Gross margin at 56.0% — affected by lower input costs, improved production efficiency, and one-offs. + EBIT margin at 26.1% — y/y improvement of ~1 percentage point
Slide 11: Financials - Outlook 2021
Financials - Outlook 2021 2021 outlook * Organic sales growth of 2% to 6% — ~1 percentage point less in reported DKK net of currency and M&A: + Food, Beverages & Human Health to grow by mid-singledigits + Grain & Tech Processing to grow by mid-single-digits + Bioenergy to grow by mid-to-high-single-
Slide 12: Status on how we track towards our mid-term targets
Status on how we track towards our mid-term targets* Mid-term targets* (2020-2022) + 5%+ organic sales growth from 2024 + EBIT margin at 28% or above * — ROIC including goodwill at 23% or above EBIT margin ROIC, incl. goodwill 28.1% 27%-28% 28%+ 23%+ ~27% iY 26% 26.1% mm 25-26%. Z 21.1% ~21% ~20% ]
Slide 13: Summary
Summary Resilient 2020 performance despite the COVID-19 pandemic. 2021 expected stronger with outlook of 2-6% organic sales growth and solid EBIT margin and FCF generation + Organic sales growth of 2% to 6% in 2021. + Built a solid foundation during 2020 and positioned to accelerate growth. + 2021 p
Slide 14: Slide 14